Difference Between Multiple Myeloma And Leukemia

What is multiple myeloma: 

This is also known as plasma cell myeloma or Kahler's disease. It is a cancer in plasma cells that typically produce antibodies. When there is only one tumor present it is called as plasmacytoma and when more than one then called as multiple myeloma.

The main cause of myeloma is unknown but the major risk factors are obesity,  inheritance chemicals, radiation, etc. With the effect of cancer, there is an abnormality in plasma cells that produces abnormal antibodies that can cause kidney problems.

At the initial stage, there is no sign and symptoms but with the advancement of time bone pain, bleeding, anemia and frequent infections are the common symptoms. Multiple myeloma is diagnosed with the help of blood or urine tests or bone marrow biopsy.
And the medication of multiple myeloma includes:

Chemotherapy- There are several drugs that are used in the treatment of multiple myeloma such as doxorubicin, etoposide, cisplatin, cyclophosphamide, etc. Chemotherapy is preferred over all other medications because of the reason that chemo drugs dissolve in the bloodstream and reach all parts of the body and destroy myeloma cells.

Blood Transfusion- A person suffering from multiple myeloma can have low blood count and does the transfusion of blood become important.

Steroid- This stimulates the hormones that are responsible for tissue growth and repair.

What is Leukemia:

Leukemia is a blood cancer that begins in the bone marrow and causes abnormal blood cells. The cause of leukemia is unknown but there are factors that enhance its rate. These factors are smoking, chemical, radiation, family history, environment, etc.

The major symptoms of leukemia include: bleeding, feeling tired, fever etc. This cancer is diagnosed by blood test or bone marrow biopsy.

There are many four types of leukemia:

  • Acute lymphoblastic leukemia (ALL). 
  • Acute myeloid leukemia (AML). 
  • Chronic lymphocytic Leukemia (CLL). 
  • Chronic myeloid leukemia (CML).

Difference Between Multiple Myeloma & Leukemia: 

There are few major differences  that are enlisted below:
  • Multiple myeloma is cancer in plasma cells  while leukemia means B cell cancer.
  • Multiple myeloma results approximately 10% of all hematologic malignancies  and leukemia results 40% of adult leukemias.
  • Plasma cell proliferative capacity in case of multiple myeloma is less while in leukemia it is more.

Read:- How to deal with final stages of multiple myeloma

Comments

Post a Comment

Popular posts from this blog

Buy Trodelvy sacituzumab govitecan-hziy in India

  Trodelvy Overview: Trodelvy is widely prescribed by Oncologists for the treatment of patients with HR+/HER2- Metastatic Breast Cancer, Metastatic Triple-Negative Breast Cancer (mTNBC), and Metastatic Urothelial Cancer (mUC). It is considered a promising treatment option for those who are not ideal candidates for some conventional therapies. Developed by Immunomedics, Trodelvy 180 mg and Trodelvy 200 mg are two available commercial strengths. Worldwide, Trodelvy is promoted and facilitated by Gilead Sciences. Trodelvy is first approved on 22 April 2020. It is given by intravenous (IV) infusion by a health specialist. The medication received its (European Medicines Agency) EMA approval in October 2021. Trodelvy 180 mg and 200 mg injections are yet to be approved in India. The cost of Trodelvy in India usually depends on international factors. Buy Trodelvy from a Reliable Source: Many suppliers who are not authorized to handle or supply life-saving medicines such as Trodelvy found ...
Read more

Lenvatinib Medication Guide

Lenvatinib is recommended for treating patients with locally recurrent, progressive, metastatic, radioactive iodine-refractory differentiated thyroid cancer (RAI-refractory DTC), together with everolimus for advanced renal cell carcinoma and for hepatocellular carcinoma.  Here are a few important points for patients before taking Lenvatinib:- Female patients who are able to become pregnant must use an effective method of birth control while on the treatment with lenvatinib and for at least 2 weeks after its last dose. Discuss with your doctor about the birth control methods you can use during this time. Lenvatinib is taken at the same time each and every day. If a patient misses any dose, and it cannot be consumed within 12 hours, then that dose must be skipped and the next dose should be consumed at the usual time of administration. The recommended dose is lenvatinib 24 mg (two lenvatinib 10 mg capsules and one lenvatinib 4 mg capsule) orally, taken once in a day, either with or...
Read more